Search - tctmd.com

Displaying 41 - 53 of 53

Sort: Relevancy | Date

News Daily News

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Yael L. Maxwell

February 22, 2016

News Daily News

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Todd Neale

January 25, 2016

News Daily News

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

L.A. McKeown

November 01, 2015

News Industry News

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

October 01, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Updated Stroke Guidelines Back the Use of Stent Retrievers in Select Patients

July 01, 2015

News Daily News

Stenting for Symptomatic Intracranial Stenosis Flops Again

Todd Neale

March 25, 2015

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

IMS III Substudy Identifies Reasons for Endovascular Treatment Delays in Acute Stroke Patients

Yael L. Maxwell

May 13, 2014

News Daily News

‘Urgent’ Stenting or Surgery Safe After Thrombolysis for Stroke

Jason Kahn

February 27, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Stenting Suitable for Extracranial Vertebral Disease

Caitlin E. Cox

July 27, 2011

Advertisement

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Updated Stroke Guidelines Back the Use of Stent Retrievers in Select Patients

Stenting for Symptomatic Intracranial Stenosis Flops Again

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

IMS III Substudy Identifies Reasons for Endovascular Treatment Delays in Acute Stroke Patients

‘Urgent’ Stenting or Surgery Safe After Thrombolysis for Stroke

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Stenting Suitable for Extracranial Vertebral Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content